UL Prospector
Prospector

成功!

成功保存搜索结果

SEIWA KASEI CO., LTD.

Visit Company Website
SEIWA KASEI Co., Ltd. develops chemicals from the hydrolysis of various natural materials, such as proteins. They evolved the technology by developing various chemically-modified derivatives of hydrolyzed protein(peptide). Their innovative technology for the fusion of peptide and silicone has allowed them to develop unique new hybrid polymers. Recently they develop the whole new technology, fusion of glycerin and physiological active substance, resulting in the birth of novel functional ingredients, such as arginine derivative and vitamin C derivatives. The company aims to maintain its unique identity while continuing to respond to the increasingly diverse requirements of their customers.
1 条结果
Silasoma™ SP SEIWA KASEI CO., LTD.
  • INCI Name:
    Polysilicone-35 (and) Ethylhexyl Methoxycinnamate (and) Diethylamino Hydroxybenzoyl Hexyl Benzoate (and) Water
Silasoma™ SP is an aqueous dispersion of encapsulated UV absorbers (60% as active component). This product is an average diameter of 2 micrometers microcapsule using amino acid as a wall material. And encapsulation eminently reduces penetration of UV abso...展开 Silasoma™ SP is an aqueous dispersion of encapsulated UV absorbers (60% as active component). This product is an average diameter of 2 micrometers microcapsule using amino acid as a wall material. And encapsulation eminently reduces penetration of UV absorbers into skin. It is suitable for sunscreen for sensitive skin or baby care. Encapsulating the UV absorbers provides a soft and light after-feel and allows for surfactant-free and safer sun protection formulations. Silasoma™ SP microcapsules contain Ethylhexyl Methoxycinnamate and Dimethylamino Hydroxybenzoyl Hexyl Benzoate. It is developed and manufactured in Japan by SEIWA KASEI. 收起
Compliance Highlights Unavailable